[go: up one dir, main page]

DE60320034D1 - Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin - Google Patents

Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin

Info

Publication number
DE60320034D1
DE60320034D1 DE60320034T DE60320034T DE60320034D1 DE 60320034 D1 DE60320034 D1 DE 60320034D1 DE 60320034 T DE60320034 T DE 60320034T DE 60320034 T DE60320034 T DE 60320034T DE 60320034 D1 DE60320034 D1 DE 60320034D1
Authority
DE
Germany
Prior art keywords
prednisolone
treatment
mastitis
cephalosporin
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60320034T
Other languages
English (en)
Other versions
DE60320034T2 (de
Inventor
Peter Gerardus Franciscus Cox
Joseph Antonius Lohuis
Selma Marianne Hensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32524018&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60320034(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of DE60320034D1 publication Critical patent/DE60320034D1/de
Application granted granted Critical
Publication of DE60320034T2 publication Critical patent/DE60320034T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60320034T 2002-12-16 2003-12-10 Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin Expired - Lifetime DE60320034T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02080265 2002-12-16
EP02080265 2002-12-16
PCT/EP2003/014051 WO2004054538A1 (en) 2002-12-16 2003-12-10 Mastitis treatment

Publications (2)

Publication Number Publication Date
DE60320034D1 true DE60320034D1 (de) 2008-05-08
DE60320034T2 DE60320034T2 (de) 2009-05-14

Family

ID=32524018

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60320034T Expired - Lifetime DE60320034T2 (de) 2002-12-16 2003-12-10 Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin

Country Status (9)

Country Link
US (1) US7812009B2 (de)
EP (1) EP1585497B1 (de)
JP (2) JP5162080B2 (de)
AT (1) ATE390124T1 (de)
AU (1) AU2003290015A1 (de)
CA (1) CA2508022C (de)
DE (1) DE60320034T2 (de)
ES (1) ES2300634T3 (de)
WO (1) WO2004054538A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7812009B2 (en) 2002-12-16 2010-10-12 Intervet International B.V. Mastitis treatment
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
EP1945223B1 (de) * 2005-10-29 2010-07-07 Intervet International BV Cefquinomzusammensetzungen und verfahren zu ihrer verwendung
AU2007291308A1 (en) * 2006-08-30 2008-03-06 Intervet International B.V. Pharmaceutical compositions comprising cefquinome
CN101148451A (zh) * 2007-05-16 2008-03-26 好维股份有限公司 一种口腔药物及口腔护理用品
EP2512504A4 (de) * 2009-12-15 2013-06-19 Dec Int Nz Ltd Behandlungszusammensetzung und -verfahren
EP2510944A1 (de) * 2011-04-15 2012-10-17 National University of Ireland, Galway Behandlung von Bakterieninfektionen
MX2013013182A (es) * 2011-05-12 2013-12-09 Intervet Int Bv Tratamiento de la mastitis.
CA2865555C (en) 2012-02-27 2021-01-12 Bayer New Zealand Limited Controlled release compositions and their methods of use
WO2014185516A1 (ja) * 2013-05-17 2014-11-20 カルピス株式会社 反芻動物の乳房炎の予防または治療剤
MX2018000962A (es) * 2015-07-29 2019-01-28 Genus Plc Metodo de reproduccion de vacas para produccion mejorada de leche.
EP3603645B1 (de) 2018-07-30 2024-08-07 Virbac Neuartige verwendung von glucocorticoiden zur behandlung von epithelialen mikrobiellen infektionen eines flüssigkeitshaltigen organs mit einer natürlichen äusseren öffnung in säugetieren
CN113209014A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效硫酸头孢喹肟混悬注射液及其制备工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU504840B2 (en) 1975-09-09 1979-11-01 Takeda Chemical Industries Ltd Medicinal compositions
JPS52110816A (en) * 1976-03-15 1977-09-17 Takeda Chem Ind Ltd Medicines
JPS5234914A (en) * 1975-09-09 1977-03-17 Takeda Chem Ind Ltd Method and composition for preventing failing of milk secretion of live stocks
US7812009B2 (en) * 2002-12-16 2010-10-12 Intervet International B.V. Mastitis treatment

Also Published As

Publication number Publication date
JP2013035845A (ja) 2013-02-21
EP1585497B1 (de) 2008-03-26
AU2003290015A1 (en) 2004-07-09
JP5162080B2 (ja) 2013-03-13
DE60320034T2 (de) 2009-05-14
CA2508022C (en) 2012-01-31
US7812009B2 (en) 2010-10-12
US20060058273A1 (en) 2006-03-16
ATE390124T1 (de) 2008-04-15
CA2508022A1 (en) 2004-07-01
EP1585497A1 (de) 2005-10-19
WO2004054538A1 (en) 2004-07-01
ES2300634T3 (es) 2008-06-16
JP2006514642A (ja) 2006-05-11

Similar Documents

Publication Publication Date Title
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
WO2004060882A8 (en) Cb 1/cb 2 receptor ligands and their use in the treatment of pain
DK1294383T3 (da) Orale sammensætninger omfattende antimikrobielle midler til at forhindre systemiske sygdomme
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
GEP20063799B (en) Tropane derivatives useful in therapy
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
IL176107A0 (en) Azabicyclic heterocycles as cannabinoid receptor modulators
DE60321929D1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
SE9900961D0 (sv) Novel compounds
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
ATE390124T1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
SE9903997D0 (sv) New compounds
SE9802208D0 (sv) Novel compounds
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
IL163951A0 (en) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
DE60128100D1 (de) Analgetisches arzneimittel
ATE500269T1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
SE0000303D0 (sv) Novel compounds

Legal Events

Date Code Title Description
8363 Opposition against the patent